|
Volumn 214, Issue 4, 2002, Pages 157-161
|
Neuroblastoma preoperatively treated as nephroblastoma: Does inadequate therapy worsen the prognosis?
a b a c c a |
Author keywords
Nephroblastoma; Neuroblastoma; Preoperative chemotherapy
|
Indexed keywords
(3 IODOBENZYL)GUANIDINE;
ANTINEOPLASTIC AGENT;
CATECHOLAMINE;
CISPLATIN;
DACARBAZINE;
DACTINOMYCIN;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
LACTATE DEHYDROGENASE;
VINCRISTINE;
VINDESINE;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CATECHOLAMINE BLOOD LEVEL;
CHILD;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG UPTAKE;
HUMAN;
MAJOR CLINICAL STUDY;
NEPHROBLASTOMA;
NEUROBLASTOMA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PREOPERATIVE EVALUATION;
PROGNOSIS;
RISK FACTOR;
ADJUVANT THERAPY;
ADOLESCENT;
CANCER STAGING;
COMPARATIVE STUDY;
DIFFERENTIAL DIAGNOSIS;
DISEASE COURSE;
FEMALE;
INFANT;
KIDNEY FUNCTION TEST;
KIDNEY TUMOR;
MALE;
MORTALITY;
PATHOLOGY;
PRESCHOOL CHILD;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
CHILD, PRESCHOOL;
DIAGNOSIS, DIFFERENTIAL;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
INFANT;
KIDNEY FUNCTION TESTS;
KIDNEY NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
MALE;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
NEUROBLASTOMA;
PROGNOSIS;
WILMS TUMOR;
|
EID: 0036629057
PISSN: 03008630
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2002-33182 Document Type: Article |
Times cited : (9)
|
References (14)
|